Merger remedies
Guidance on merger remedies in Phase 1 and Phase 2 investigations.
Documents
Details
This guidance is intended for merger parties and their advisers. It seeks to provide a single source of guidance on remedies for Phase 1 and Phase 2 merger investigations. This guidance applies to any Phase 1 merger investigations commenced after 13 December 2018 and any Phase 1 merger investigations referred to Phase 2 after 13 December 2018 and supersedes the Competition Commission (CC) guidelines on merger remedies (CC8), Chapter 5 of the Office of Fair Trading (OFT) guidelines on undertakings in lieu of reference (UILs) (OFT1122) and Chapters 8 and 14 of the CMA’s guidelines on merger jurisdiction and procedure (CMA2). For any Phase 2 merger investigations that commenced prior to 13 December 2018, the previous guidance remains applicable.
Updates to this page
-
The merger remedies guidance has been updated following consultation.
-
First published.